Abstract
Mefloquine was compared with sulfadoxine—pyrimethamine for safety and efficacy in a randomized, double-blind clinical trial in adult males from a malaria-endemic area of Brazil. A total of 99 oligosymptomatic and symptomatic volunteers with Plasmodium falciparum parasitaemia took part in the trial; 49 were given 1000 mg of mefloquine and the remainder received 1500 mg of sulfadoxine plus 75 mg of pyrimethamine, in a single oral dose.
Mefloquine was 100% successful in clearing parasitaemia within 7 days; there were no recrudescences. Sulfadoxine—pyrimethamine was less successful; 35 cases showed an S-type response, 8 an RI response, 3 an RII, and 2 an RIII response. The side-effects of mefloquine were mild and transient and included headache, nausea, vomiting, dizziness, and diarrhoea. A satisfactory weight gain and rise in haemoglobin level were seen in both groups.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clyde D. F., McCarthy V. C., Miller R. M., Hornick R. B. Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother. 1976 Mar;9(3):384–386. doi: 10.1128/aac.9.3.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harinasuta T., Dixon K. E., Warrell D. A., Doberstyn E. B. Recent advances in malaria with special reference to Southeast Asia. Southeast Asian J Trop Med Public Health. 1982 Mar;13(1):1–34. [PubMed] [Google Scholar]
- Rozman R. S., Canfield C. J. New experimental antimalarial drugs. Adv Pharmacol Chemother. 1979;16:1–43. doi: 10.1016/s1054-3589(08)60241-0. [DOI] [PubMed] [Google Scholar]
- YOUNG M. D., MOORE D. V. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg. 1961 May;10:317–320. doi: 10.4269/ajtmh.1961.10.317. [DOI] [PubMed] [Google Scholar]
- da SILVA J., LOPES P. F., FERREIRA L. F., MORTEO R., NAVEIRA J. B. [Resistance of P. falciparum to the action of chloroquine (preliminary note)]. Hospital (Rio J) 1961 Nov;60:581–594. [PubMed] [Google Scholar]
